Cargando…

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy

The reply letter has been put forth in response to the comment made by Karthyayani Priya Satish entitled “India and the COVID-19 Vaccine.” The comment was made in context to our published work “Exploring the covid-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Gaurav, Poduri, Ramarao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009944/
https://www.ncbi.nlm.nih.gov/pubmed/35240913
http://dx.doi.org/10.1080/21645515.2022.2034458